De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion-Reference-Cited by-同舟云学术

De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion

Published:2022-11-30 Issue:1 Volume:27 Page:1259-1262
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Hameed Maha¹,Alnoamani Mohammed²,Marei Mohammed²,Tailor Imran²,Alshehri Hassan²,Tashkandi Soha A.³,Alswayyed Azizah³,Alrajhi Abdullah M.⁴⁵,Zaidi Syed Z. A.²,Motabi Ibraheem²,AlShehry Nawal²,Alfayez Mansour¹²⁶

Affiliation:

1. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

2. Department of Hematology, King Fahad Medical City, Riyadh, Saudi Arabia

3. Cytogenetics Laboratory, Department of Clinical Pathology, King Fahad Medical City, Riyadh, Saudi Arabia

4. Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia

5. Department of Pharmacy Practice, College of Pharmacy, AlFaisal University, Riyadh, Saudi Arabia

6. Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2022.2150386

Reference12 articles.

1. Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

2. Sudden blastic transformation in treatment‐free remission chronic myeloid leukaemia

3. The Clinical Impact of Time to Response in De Novo Accelerated Phase Chronic Myeloid Leukemia (CML-AP)

4. Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

5. Insights into the stem cells of chronic myeloid leukemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytarabine/dexamethasone/hydroxycarbamide;Reactions Weekly;2023-01-07